| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |